Benitec biopharma limited

Major-Pharmaceuticals

BNTC


99 Mount Street
North Sydney , NSW 2060

Executive/
Director

Price

  • Last Close
  • $ 0.2
    $ -0.01 -4.25 %
    Jul 25, 2023
  • 52-Week High/Low
  • $0 - $0
  • YTD
  • 0%

  • Trading Volume
  • 1,690,333
  • Market Cap Full
  • $ 514.5K
  • Shares Outstanding
  • 2.6M
    Nov 7, 2023
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Q1 -57.5% 80.4% 7.4% 30.7% -5% 64% -13.6% 23.5% - -
Q2 -25.7% -33% -38.6% -60.1% 4% -13.6% -48.8% 13.8% - -
Q3 10.2% 17.3% 15.1% -10.3% 8% -16% -67.9% -15.1% - -
Q4 9.3% 36.4% -39% 600% -53.5% -26.6% -54.3% - - -
J F M A M J J A S O N D
2025 - - - - - - - - - - - -
2024 - - - - - - - - - - - -
    2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
    0%-62%93%-49%227%-39%-13%-94%19%0%0%

Earnings

2016 2017 2018 2019 2020 2021 2022 2023
Q1 - 0.01 0.22 - -392.53 -164.69 -0.4 -2.72
Q2 - 0.20 0.20 - - 160.27 122.76 1,590.64
Q3 0.08 0.22 - -268 -490 -124 -94 -2.76
Q4 0.36 0.22 - - -151.26 -118 -3.40 -
A 0.4 0.7 0.4 -268 -1033.8 -3.2 -37.9 -14.1

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2020 2021 2022 2023
Mar - 4.5 8.2 28
Jun - 7.9 8.2 28
Sep 1.1 8.2 8.2 2.5
Dec 4.4 8.2 28 2.6

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover - - - - -
Fixed Asset Turnover - - - - 10.6
Total Asset Turnover - - - 0.7 0.2
Leverage
Debt Ratio - - - - -
Debt – Equity Ratio - - - - -
Interest Coverage - - - - -134.3
Equity multiplier - - - - -